Lemaitre Vascular (LMAT) Misses Q1 EPS by 1c

Lemaitre Vascular (NASDAQ: LMAT) reported Q1 EPS of $0.27, $0.01 worse than the analyst estimate of $0.28. Revenue for the quarter came in at $39.6 million versus the consensus estimate of $38.65 million.

GUIDANCE:

Lemaitre Vascular sees FY2022 EPS of $1.21-$1.31, versus the consensus of $1.40. Lemaitre Vascular sees FY2022 revenue of $160-164 million, versus the consensus of $165 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Deere & Co. (DE) Tops Q3 EPS by 41c, raises guidance
• The Buckle (BKE) Tops Q2 EPS by 7c, Beats on Revenue